Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Colonic Neoplasms × Drug Evaluation × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 4 Leukemia, Myeloid, Acute 3 Colorectal Neoplasms 3 Lymphoma, Non-Hodgkin 2 Carcinoma, Basal Cell 2 Breast Diseases 2 Basal Cell Nevus Syndrome 2 Upper Tract Urothelial Carcinomas 1 Thrombocythemia, Essential 1 Solid Tumors 1 Serous Ovarian Cancer 1 Recurrence 1 Postmenopausal Women With ER+ HER2- Primary Breast Cancer 1 Polycythemia Vera 1 Ovarian Neoplasms 1 Lymphedema 1 Liver Neoplasms 1 Leukemia 1 Immunoglobulin Light-chain Amyloidosis 1 Hypogonadism 1 Glioma 1 Gastric Adenocarcinoma 1 Fatigue Syndrome, Chronic 1 Eunuchism 1 Colonic Neoplasms 1 Amyloidosis 1 Adenoma 1

Interventions

Fluorouracil 219 Leucovorin 202 Oxaliplatin 191 Irinotecan 150 Bevacizumab 110 Capecitabine 93 Cetuximab 90 Folfox protocol 54 Chemotherapy, Adjuvant 35 Panitumumab 30 Colonoscopy 30 pembrolizumab 23 Nivolumab 22 Drug Therapy 22 Magnetic Resonance Spectroscopy 21 Gemcitabine 20 Blood Specimen Collection 20 Radiotherapy 19 Floxuridine 19 Biopsy 19 Neoadjuvant Therapy 18 Laparoscopy 18 IFL protocol 18 Early Intervention, Educational 18 Celecoxib 18 Surveys and Questionnaires 17 Surgical Procedures, Operative 16 Immunohistochemistry 16 Exercise 15 trifluridine tipiracil drug combination 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05189171 2024-06-28

MODEL-CRC

Xilis, Inc.

Gastrointestinal

Colonic Neoplasms, Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡